Biomade Life Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.00 M
as on 24-10-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.21 Cr
as on 24-10-2024
- Revenue 2.28%
(FY 2023)
- Profit 0.19%
(FY 2023)
- Ebitda 32.68%
(FY 2023)
- Net Worth 21.69%
(FY 2023)
- Total Assets 17.20%
(FY 2023)
About Biomade Life Care
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.21 Cr.
Anil Shahi, Riyaz Khan, and Mohamad Chaudhary serve as directors at the Company.
- CIN/LLPIN
U24304PB2020PTC050539
- Company No.
050539
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Mohali, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Biomade Life Care?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Shahi  | Director | 06-Jan-2020 | Current |
| Riyaz Khan | Director | 06-Jan-2020 | Current |
| Mohamad Chaudhary | Director | 06-Jan-2020 | Current |
Financial Performance of Biomade Life Care.
Biomade Life Care Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.28% increase. The company also saw a slight improvement in profitability, with a 0.19% increase in profit. The company's net worth Soared by an impressive increase of 21.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biomade Life Care?
Unlock access to Biomade Life Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Biomade Life Sciences LlpActive 5 years 3 monthsAnil Shahi, Riyaz Khan and 1 more are mutual person
- Chrysalis Pharma Private LimitedActive 10 years 6 months
Anil Shahi and Riyaz Khan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Mar 2023 | ₹2.30 Cr | Open |
Others Creation Date: 30 Dec 2020 | ₹9.16 M | Open |
How Many Employees Work at Biomade Life Care?
Unlock and access historical data on people associated with Biomade Life Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biomade Life Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomade Life Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
